| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Philippe Huot, André Paren. Dopaminergic neurons intrinsic to the striatum. Journal of neurochemistry. vol 101. issue 6. 2007-08-16. PMID:17286588. |
the dopaminergic nature of these neurons is further supported by the fact that they express the dopamine (da) transporter (dat) and the nuclear orphan receptor nurr1, a transcription factor essential for the expression of the da phenotype by midbrain neurons. |
2007-08-16 |
2023-08-12 |
Not clear |
| Michael A van der Kooij, Jeffrey C Glenno. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neuroscience and biobehavioral reviews. vol 31. issue 4. 2007-08-16. PMID:17316796. |
while the involvement of dopamine (da) in adhd has been established, the evaluation of rodent models of adhd particularly with respect to dopaminergic systems is attempted here. |
2007-08-16 |
2023-08-12 |
mouse |
| Hideo Matsuzaki, Yoshio Minabe, Kazuhiko Nakamura, Katsuaki Suzuki, Yasuhide Iwata, Yoshimoto Sekine, Kenji J Tsuchiya, Genichi Sugihara, Shiro Suda, Nori Takei, Daiichiro Nakahara, Kenji Hashimoto, Angus C Nairn, Norio Mori, Kohji Sat. Disruption of reelin signaling attenuates methamphetamine-induced hyperlocomotion. The European journal of neuroscience. vol 25. issue 11. 2007-08-15. PMID:17553006. |
to clarify whether reelin signaling is involved in dopaminergic neurotransmission in the adult mouse brain, we investigated dopamine function in mice lacking reelin (reeler). |
2007-08-15 |
2023-08-12 |
mouse |
| Hideo Matsuzaki, Yoshio Minabe, Kazuhiko Nakamura, Katsuaki Suzuki, Yasuhide Iwata, Yoshimoto Sekine, Kenji J Tsuchiya, Genichi Sugihara, Shiro Suda, Nori Takei, Daiichiro Nakahara, Kenji Hashimoto, Angus C Nairn, Norio Mori, Kohji Sat. Disruption of reelin signaling attenuates methamphetamine-induced hyperlocomotion. The European journal of neuroscience. vol 25. issue 11. 2007-08-15. PMID:17553006. |
next, we examined the locomotor response to intra-accumbens injection of dopamine d1 and d2 receptor agonists, and found that lack of reelin signaling results in decreases in both d1 and d2 receptor-mediated dopaminergic functions. |
2007-08-15 |
2023-08-12 |
mouse |
| Jiann-Der Lee, Chung-Hsien Huang, Yi-Hsin Weng, Kun-Ju Lin, Chin-Tu Che. An automatic MRI/SPECT registration algorithm using image intensity and anatomical feature as matching characters: application on the evaluation of Parkinson's disease. Nuclear medicine and biology. vol 34. issue 4. 2007-08-13. PMID:17499735. |
single-photon emission computed tomography (spect) of dopamine transporters with (99m)tc-trodat-1 has recently been proposed to offer valuable information in assessing the functionality of dopaminergic systems. |
2007-08-13 |
2023-08-12 |
human |
| Louis R Lucas, Ching-Jung Wang, Trudy J McCall, Bruce S McEwe. Effects of immobilization stress on neurochemical markers in the motivational system of the male rat. Brain research. vol 1155. 2007-08-13. PMID:17511973. |
a trio of indirect markers associated with dopaminergic activity was measured including dopamine transporter (dat) and dopamine d2 receptor subtype (d2r) ligand levels as well as mrna levels of the endogenous opioid enkephalin (enk-mrna). |
2007-08-13 |
2023-08-12 |
rat |
| Jiann-Der Lee, Chung-Hsien Huang, Yi-Hsin Weng, Kun-Ju Lin, Chin-Tu Che. Improved accuracy of brain MRI/SPECT registration using a two-cluster SPECT normalization algorithm and a combinative similarity measure: application to the evaluation of Parkinson's disease. Annals of nuclear medicine. vol 21. issue 4. 2007-08-09. PMID:17581718. |
single-photon emission computed tomography (spect) of dopamine transporters with technetium-99-labeled tropane derivative (99m)tc-trodat-1 has recently been suggested to offer valuable information in assessing the functionality of dopaminergic systems. |
2007-08-09 |
2023-08-12 |
Not clear |
| Muzamil Ahmad, Seema Yousuf, M Badruzzaman Khan, Abdullah Shafique Ahmad, Sofiyan Saleem, Md Nasrul Hoda, Fakhrul Isla. Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease. Human & experimental toxicology. vol 25. issue 7. 2007-08-08. PMID:16898164. |
a significant decrease in the level of dopamine (da) and its metabolites and an increase in the number of dopaminergic d2 receptors in striatum were observed after 6-ohda injection, both parameters were significantly recovered with treatment of the extract. |
2007-08-08 |
2023-08-12 |
rat |
| Clete A Kushid. Pramipexole for the treatment of restless legs syndrome. Expert opinion on pharmacotherapy. vol 7. issue 4. 2007-08-07. PMID:16503816. |
rls may be treated by dopaminergic agents, benzodiazepines, anticonvulsants and opiates; dopamine agonists are currently considered first-line therapy for this condition. |
2007-08-07 |
2023-08-12 |
Not clear |
| Sung-Wook Chae, Yeo Jin Bang, Kyeong-Man Kim, Kwang Youl Lee, Bok Yun Kang, Eun Mee Kim, Hiroyasu Inoue, Onyou Hwang, Hyun Jin Cho. Role of cyclooxygenase-2 in tetrahydrobiopterin-induced dopamine oxidation. Biochemical and biophysical research communications. vol 359. issue 3. 2007-08-07. PMID:17560944. |
dopamine is considered one of the main contributing factors in the induction of oxidative stress and selective dopaminergic neurodegeneration in parkinson's disease. |
2007-08-07 |
2023-08-12 |
rat |
| Sung-Wook Chae, Yeo Jin Bang, Kyeong-Man Kim, Kwang Youl Lee, Bok Yun Kang, Eun Mee Kim, Hiroyasu Inoue, Onyou Hwang, Hyun Jin Cho. Role of cyclooxygenase-2 in tetrahydrobiopterin-induced dopamine oxidation. Biochemical and biophysical research communications. vol 359. issue 3. 2007-08-07. PMID:17560944. |
these data suggest that bh4-induced cox-2 expression is responsible for dopamine oxidation, leading to the preferential vulnerability of dopaminergic cells in parkinson's disease. |
2007-08-07 |
2023-08-12 |
rat |
| Verena Ludwig, Rainer K W Schwartin. Neurochemical and behavioral consequences of striatal injection of 5,7-dihydroxytryptamine. Journal of neuroscience methods. vol 162. issue 1-2. 2007-08-06. PMID:17287026. |
this dopaminergic lesion was prevented in a second experiment, where rats were pre-treated systemically with the dopamine reuptake inhibitor nomifensine. |
2007-08-06 |
2023-08-12 |
rat |
| Maria C Abay, Janet Delos Reyes, Katheryn Everts, Jessica Wisse. Current literature questions the routine use of low-dose dopamine. AANA journal. vol 75. issue 1. 2007-08-06. PMID:17304785. |
dopamine infused at low doses is thought to be specific to dopaminergic receptors. |
2007-08-06 |
2023-08-12 |
Not clear |
| Michael J Parsons, Ignacio Mata, Maria Beperet, Fernando Iribarren-Iriso, Barbara Arroyo, Ricardo Sainz, Maria J Arranz, Robert Kerwi. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatric genetics. vol 17. issue 3. 2007-08-06. PMID:17417059. |
association studies of dopaminergic genes such as the dopamine d2 receptor gene (drd2), however, have produced contradictory results. |
2007-08-06 |
2023-08-12 |
Not clear |
| Pietro Mazzoni, Anna Hristova, John W Krakaue. Why don't we move faster? Parkinson's disease, movement vigor, and implicit motivation. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 27. issue 27. 2007-08-02. PMID:17611263. |
we propose that, analogous to the established role of dopamine in explicit reward-seeking behavior, the dopaminergic projection to the striatum provides a signal for implicit "motor motivation." |
2007-08-02 |
2023-08-12 |
human |
| Ikwunga Wonodi, Braxton D Mitchell, O Colin Stine, L Elliot Hong, Amie Elliott, Brian Kirkpatrick, William T Carpenter, Gunvant K Thaker, Robert W Buchana. Lack of association between COMT gene and deficit/nondeficit schizophrenia. Behavioral and brain functions : BBF. vol 2. 2007-07-31. PMID:17173666. |
the dopamine dysregulation hypothesis of schizophrenia posits that positive, negative and cognitive symptoms correlate with cortical/subcortical imbalances in dopaminergic transmission. |
2007-07-31 |
2023-08-12 |
Not clear |
| T Abekawa, K Ito, T Koyam. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex. Naunyn-Schmiedeberg's archives of pharmacology. vol 374. issue 3. 2007-07-30. PMID:17103144. |
therefore, clz may block pcp-induced acute increases in glutamate levels in the mpfc by an enhancement of the nmda receptor-mediated neurotransmission that is not accelerated by an enhanced dopaminergic transmission via dopamine d(1) receptors. |
2007-07-30 |
2023-08-12 |
rat |
| David H Ben-Dor, Sharon Zimmerman, Jonathan Sever, Neta Roz, Alan Apter, Moshe Rehavi, Abraham Weizma. Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 17. issue 8. 2007-07-30. PMID:17344033. |
if the lower platelet vmat2 density also occurred in the brain, it may have serve as an adaptive mechanism geared to decrease dopamine storage in the presynaptic neurons and thereby to attenuate the dopaminergic overactivity and ameliorate the movement disorder. |
2007-07-30 |
2023-08-12 |
Not clear |
| Mei-Ping Kung, Catherine Hou, Rajesh Goswami, Datta E Ponde, Michael R Kilbourn, Hank F Kun. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters. Nuclear medicine and biology. vol 34. issue 3. 2007-07-30. PMID:17383573. |
when [(18)f]fp-(+)-dtbz and [(125)i]ipt ((n-(3'-iodopropen-2'-yl)-2-beta-carbomethoxy-3-beta-(4-chlorophenyl)tropane, a selective marker for dopamine transporters (dats) in dopaminergic neurons) were simultaneously injected into lesioned mice, we observed an excellent correlation (r=0.95) for these tracers. |
2007-07-30 |
2023-08-12 |
mouse |
| Tanuja Bordia, Sharon R Grady, J Michael McIntosh, Maryka Qui. Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum. Molecular pharmacology. vol 72. issue 1. 2007-07-30. PMID:17409284. |
parkinson's disease is a neurodegenerative movement disorder characterized by a loss of substantia nigra dopamine neurons, and corresponding declines in molecular components present on striatal dopaminergic nerve terminals. |
2007-07-30 |
2023-08-12 |
mouse |